The invention relates generally to medical devices. More specifically, the invention relates to intracorporal medical devices, such as a guidewire, catheter, or the like, including structure for crossing an occlusion in a vessel of a patient.
The use of intravascular medical devices has become an effective method for treating many types of vascular disease. In general, one or more suitable intravascular device is inserted into the vascular system of the patient and navigated through the vasculature to a desired target site. Using this method, virtually any target site in the patient's vascular system may be accessed, including the coronary, cerebral, and peripheral vasculature. Examples of therapeutic purposes for intravascular devices include percutaneous transluminal angioplasty (PTA) and percutaneous transluminal coronary angioplasty (PTCA).
When in use, intravascular devices, such as a guidewire, may enter the patient's vasculature at a convenient location and then is urged to a target region in the anatomy. The path taken within the anatomy of a patient may be very tortuous, and as such, it may be desirable to combine a number of performance features in the intravascular device. For example, it is sometimes desirable that the device have a relatively high level of pushability and torqueability, particularly near its proximal end. It is also sometimes desirable that a device be relatively flexible, particularly near its distal end, for example, to aid in steering.
In addition, medical devices, such as a guidewire, catheter, or the like, will sometimes confront an occlusion, such as a lesion and/or stenosis when passing through the vasculature to a target location. In some cases, the occlusion may completely block the vessel as is the case with a chronic total occlusion. The success of the procedure often depends on the ability to insert the medical device through the occlusion.
A number of different elongated medical device structures, assemblies, and methods are known, each having certain advantages and disadvantages. However, there is an ongoing need to provide alternative elongated medical device structures, assemblies, and methods. In particular, there is an ongoing need to provide alternative medical devices including structure or assemblies configured to aid in crossing an occlusion in a vessel of a patient, and methods of making and using such structures and/or assemblies.
The invention provides several alternative designs, materials and methods of manufacturing and using alternative elongated medical device structures and assemblies. Some example embodiments relate to a medical device, such as a guidewire, catheter, or the like, that includes an elongated tubular member that includes a plurality of angled slots defined in at least a distal section thereof. The plurality of angled slots can form a generally spiral shaped pattern about the longitudinal axis of the tubular member, and can be useful, for example, in aiding a user of the device in crossing an occlusion in a vessel of a patient. For example, when an occlusion is engaged with the medical device, a rotational force may be applied such that the angled slots and/or one or more spiral shaped structure defined by the angled slots may engage the occlusion and may aid in pulling and/or drawing at least a portion of the medical device through the occlusion. In some embodiments, the distal section of the tubular member may have an outer diameter that is greater than the outer diameter of a proximal section of the tubular member. In some embodiments, a proximal section of the tubular member may include a plurality of slots defined therein, for example, that may be configured to increase the lateral flexibility of the tubular member. A number of alternative embodiments, including alternative structures and assemblies, and methods of making and using are also disclosed.
The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present invention. The Figures, and Detailed Description which follow more particularly exemplify these embodiments.
The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:
While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.
The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
As will be appreciated, at least some embodiments relate to a medical device that includes a tubular member having a plurality of angled slots defined in at least the distal section thereof, the angles slots forming a generally spiral shaped pattern about a portion of the tubular member. Such a tubular member may be used, for example, in the medical device to aid in crossing an occlusion in a vessel of a patient, as will be discussed in more detail below.
Refer now to
The guidewire 10 may also include a core member 30 that may be attached to the tubular member 20, and extend from a location within the tubular member 20 and/or from the proximal end 28 of the tubular member 20 to the proximal end 18 of the guidewire 10. However, in other embodiments, the core member 30 may be absent, and/or the tubular member 20 may extend to the proximal end 18 of the guidewire 10. For example, in some other embodiments, the tubular member 20 may extend along substantially the entire length of the guidewire 10, for example, form the proximal end 18 to the distal end 16, and the core member 30 may be present and disposed within at least a portion of the tubular member 20, or may be absent, as desired. A distal tip member 32 may be disposed at the distal end 26 of the tubular member 20 and/or the distal end 16 of the guidewire 10. The distal tip member 32 may be any or a broad variety of suitable structures, for example, a solder tip, a weld tip, a pre-made or pre-formed metallic or polymer structure, or the like, that is attached or joined to the distal end of the tubular member 20 using a suitable attachment technique.
Referring now to
As indicated above, the tubular member 20 includes both a distal section 22 and a proximal section 24. In some embodiments, tubular member 20 may be a single, continuous and/or uninterrupted and/or one-piece and/or monolithic tubular member that defines both the proximal and distal sections 22/24. In other embodiments, as shown in
As can also be appreciated, in some embodiments, the distal section 22, or portions thereof, can have an outer diameter that is greater than the outer diameter of the proximal section 24. In some embodiments, this may provide for certain benefits. For example, the distal section 22, due to its greater diameter, may be better adapted to engage an occlusion in a vessel of a patient, as will be discussed below. Additionally, the proximal section 24, due to its reduced diameter relative to the distal section 22, may extend through a pathway in an occlusion created by the larger distal section 22 with a reduced amount of drag and/or engagement with the occlusion and/or other parts of the vessel. Additionally, the proximal section, due to its reduced diameter, may also be provided with greater flexibility relative to the distal section 22. These are but of few examples of some benefits that may be realized due to the distal section 22 including a greater outer diameter than the proximal section 24 of the tubular member 22. In other embodiments, however, the outer diameter of the distal section 22, or portions thereof, may be the same or smaller than the outer diameter of the proximal section, as will be discussed in more detail below. In embodiments where the distal and proximal sections 22/24 are two discrete and/or separate components that are attached, the variances in the outer diameters can be provided by the use of different discrete tubular components having different outer diameters. In embodiments where the tubular member 20 is a one-piece or monolithic member, the variances in the outer diameters can be provided by grinding or otherwise working the tubular member 20 to provide the desired diameters.
The distal section 22 includes a plurality of angled cuts, apertures, and/or slots 52 defined in the wall 33. This plurality of angled slots 52 can be disposed such that they form one or more generally spiral-shaped pattern in the distal section 22 of the tubular member 20 about the longitudinal axis x. In other words, the slots 52 can be disposed and/or created such that they are at an angle relative to the longitudinal axis x, and a plurality of the angled slots 52 in combination may form a generally spiral-shaped pattern about the longitudinal axis x. For example, the slots 52 may include a center line y that extends both laterally along and radially about the longitudinal axis x. The center line y may lie in a plane that can define an angle Θ with the longitudinal axis x, and the angle Θ is generally less than about 90°. In some embodiments, the angle Θ may be in the range of about 35° to 85°, or from about 40° to 80°, or from about 45° to 75°, or from about 50° to 70°. In some cases, the angle Θ may be about 50°, about 60°, about 70°, or about 80°. In some embodiments, at least some, if not all of the slots 52 are disposed at the same or a similar angle. However, in other embodiments, one or more slots 52 may be disposed at different angles relative to other slots 52. Because the slots 52 are angled relative to the longitudinal axis x, and the outer surface of the tubular member 20 is curved, the slots 52 can take a curved, and/or spiral-like shape about a portion of the outer surface of the tubular member 20. As such, a plurality of the slots 52 may be used to create one or more generally spiral-shaped pattern about the outer surface of the tubular member 20.
In some embodiments, each individual slot 52 extends only partially in a radial manner about the longitudinal axis x. In other words, each slot 52 makes less than one full revolution about the longitudinal axis x. For example,
In some embodiments, a spiral shaped pattern can be formed by aligning and/or arranging at least some of the slots 52 in combination such that they form what may be characterized as a generally non-continuous spiral groove that extends radially about the outer surface of the distal section 22. For example, with reference to
The generally spiral-shaped pattern shown in
The embodiment shown in
For example, refer to
In at least some embodiments, the spiral-shaped pattern of slots 52 and/or spiral-shaped remaining structure in the distal section 22 may be configured to aid a user to cross an occlusion in a vessel of a patient. For example, the distal section 22, including such a spiral-shaped pattern of slots and/or spiral-shaped remaining structure, may be configured to function as a screw-like, auger-like, and/or threaded member that may engage the occlusion and draw itself and/or a portion of the guidewire 10 into and/or through the occlusion when a predetermined rotational force is applied to the guidewire. Some examples of such uses are discussed below. Additionally, the slots 52 can be disposed in a pattern that provides the desired degree of lateral flexibility while maintaining a desired degree of tortional stiffness.
Referring back to
Any of the above mentioned slots, for example slots 52 or 60, can be formed in essentially any known way. For example, slots 52 or 60 can be formed by methods such as micro-machining, saw-cutting, laser cutting, grinding, milling, casting, molding, chemically etching or treating, or other known methods, and the like. In some such embodiments, the structure of the tubular member 20 is formed by cutting and/or removing portions of the tube to form slots 52/60. Some example embodiments of appropriate micromachining methods and other cutting methods, and structures for tubular members and medical devices including tubular members are disclosed in U.S. Patent Publication No. U.S. 2003/0069522 entitled “Slotted Medical Device” filed Aug. 5, 2002; U.S. Patent Publication No. 2004/0181174-A2 entitled “Medical device for navigation through anatomy and method of making same” filed on Jul. 25, 2003; U.S. Pat. No. 6,766,720; and U.S. Pat. No. 6,579,246, the entire disclosures of which are herein incorporated by reference. Some example embodiments of etching processes are described in U.S. Pat. No. 5,106,455, the entire disclosure of which is herein incorporated by reference.
Forming the tubular member 20, or sections thereof, may include any one of a number of different techniques. For example, the tubular member 20, including the distal and proximal sections 22/24 and/or components, may be created by casting or forming methods, stamping methods, or the like, and may be shaped or otherwise worked, for example, by centerless grinding methods, into the desired shape and/or form. A centerless grinding technique may utilize an indexing system employing sensors (e.g., optical/reflective, magnetic) to avoid excessive grinding of the connection. In addition, the centerless grinding technique may utilize a CBN or diamond abrasive grinding wheel that is well shaped and dressed to avoid grabbing tubular member 20 during the grinding process. In some embodiments, tubular member 20 is centerless ground using a Royal Master HI-AC centerless grinder.
Refer now to
The materials that can be used for the various components of guidewire 10 may include those commonly associated with medical devices. For example, core member 30 and/or tubular member 20 may be made from a metal, metal alloy, a metal-polymer composite, and the like, or any other suitable material. Some examples of suitable metals and metal alloys include stainless steel, such as 304V, 304L, and 316LV stainless steel; mild steel; nickel-titanium alloy such as linear-elastic or super-elastic nitinol, nickel-chromium alloy, nickel-chromium-iron alloy, cobalt alloy, tungsten or tungsten alloys, MP35-N (having a composition of about 35% Ni, 35% Co, 20% Cr, 9.75% Mo, a maximum 1% Fe, a maximum 1% Ti, a maximum 0.25% C, a maximum 0.15% Mn, and a maximum 0.15% Si), hastelloy, monel 400, inconel 625, or the like; other Co—Cr alloys; platinum enriched stainless steel; or other suitable material.
As alluded to above, within the family of commercially available nickel-titanium or nitinol alloys, is a category designated “linear elastic” which, although it may be similar in chemistry to conventional shape memory and superelastic varieties, exhibits distinct and useful mechanical properties. By the applications of cold work, directional stress, and heat treatment, the material is fabricated in such a way that it does not display a substantial “superelastic plateau” or “flag region” in its stress/strain curve. Instead, as recoverable strain increases, the stress continues to increase in a generally linear relationship (as compared to that of super-elastic material, which has a super-elastic plateau) until plastic deformation begins. In some embodiments, the linear elastic nickel-titanium alloy is an alloy that does not show any substantial martensite/austenite phase changes that are detectable by DSC and DMTA analysis over a large temperature range.
For example, in some embodiments, there are no substantial martensite/austenite phase changes detectable by DSC and DMTA analysis in the range of about −60° C. to about 120° C. The mechanical bending properties of such material are therefore generally inert to the effect of temperature over this very broad range of temperature. In some particular embodiments, the mechanical properties of the alloy at ambient or room temperature are substantially the same as the mechanical properties at body temperature. In some embodiments, the use of the linear elastic nickel-titanium alloy allows the guidewire to exhibit superior “pushability” around tortuous anatomy. Accordingly, components of guidewire 10 such as core member 30 and/or tubular member 20 may include linear elastic nickel-titanium alloy.
In some embodiments, the linear elastic nickel-titanium alloy is in the range of about 50 to about 60 weight percent nickel, with the remainder being essentially titanium. In some embodiments, the composition is in the range of about 54 to about 57 weight percent nickel. One example of a suitable nickel-titanium alloy is FHP-NT alloy commercially available from Furukawa Techno Material Co. of Kanagawa, Japan. Some examples of nickel titanium alloys are disclosed in U.S. Pat. Nos. 5,238,004 and 6,508,803, which are incorporated herein by reference. In some other embodiments, a superelastic alloy, for example a superelastic nitinol can be used to achieve desired properties.
In at least some embodiments, portions or all of core member 30 and/or tubular member 20, or other components that are part of or used in the device, may be doped with, made of, or otherwise include a radiopaque material. Radiopaque materials are understood to be materials capable of producing a relatively bright image on a fluoroscopy screen or another imaging technique during a medical procedure. This relatively bright image aids the user of device 10 in determining its location. Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, polymer material loaded with a radiopaque filler, and the like. Additionally, radiopaque marker bands and/or coils may be incorporated into the design of guidewire 10 to achieve the same result.
In some embodiments, a degree of MRI compatibility is imparted into device 10. For example, to enhance compatibility with Magnetic Resonance Imaging (MRI) machines, it may be desirable to make core member 30 and/or tubular member 20, or other portions of the medical device 10, in a manner that would impart a degree of MRI compatibility. For example, core member 30 and/or tubular member 20, or portions thereof, may be made of a material that does not substantially distort the image and create substantial artifacts (artifacts are gaps in the image). Certain ferromagnetic materials, for example, may not be suitable because they may create artifacts in an MRI image. Core member 30 and/or tubular member 20, or portions thereof, may also be made from a material that the MRI machine can image. Some materials that exhibit these characteristics include, for example, tungsten, Elgiloy, MP35N, nitinol, and the like, and others.
Referring now to core member 30, the entire core member 30 can be made of the same material along its length, or in some embodiments, can include portions or sections made of different materials. In some embodiments, the material used to construct core member 30 is chosen to impart varying flexibility and stiffness characteristics to different portions of core member 30. For example, the proximal region and the distal region of core wire 30 may be formed of different materials, for example materials having different moduli of elasticity, resulting in a difference in flexibility. In some embodiments, the material used to construct the proximal region can be relatively stiff for pushability and torqueability, and the material used to construct the distal region can be relatively flexible by comparison for better lateral trackability and steerability. For example, the proximal region can be formed of straightened 304v stainless steel wire or ribbon and the distal region can be formed of a straightened super elastic or linear elastic alloy, for example a nickel-titanium alloy wire or ribbon.
In embodiments where different portions of core member 30 are made of different materials, the different portions can be connected using any suitable connecting techniques. For example, the different portions of core member 30 can be connected using welding (including laser welding), soldering, brazing, adhesive, or the like, or combinations thereof. Additionally, some embodiments can include one or more mechanical connectors or connector assemblies to connect the different portions of core member 30 that are made of different materials. The connector may include any structure generally suitable for connecting portions of a guidewire. One example of a suitable structure includes a structure such as a hypotube or a coiled wire which has an inside diameter sized appropriately to receive and connect to the ends of the proximal portion and the distal portion. Some other examples of suitable techniques and structures that can be used to interconnect different shaft sections are disclosed in U.S. Pat. Nos. 6,918,882 and 7,074,197, and U.S. Publication No. 2004/0167441 entitled “Composite Medical Device” filed on Feb. 26, 2003, all of which are incorporated herein by reference in their entirety.
Core member 30 can have a solid cross-section, for example a core wire, but in some embodiments, can have a hollow cross-section. In yet other embodiments, core member 30 can include a combination of areas having solid cross-sections and hollow cross sections. Moreover, core member 30, or portions thereof, can be made of rounded wire, flattened ribbon, or other such structures having various cross-sectional geometries. The cross-sectional geometries along the length of core member 30 can also be constant or can vary. For example,
In some embodiments, a sheath and/or coating, for example a lubricious, a hydrophilic, a protective, or other type of material may be applied over portions or all of the core member 30 and/or tubular member 20, or other portions of device 10. Some examples of suitable polymer sheath materials may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane, polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly(alkylene ether) phthalate and/or other polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), ethylene vinyl acetate copolymers (EVA), silicones, polyethylene (PE), Marlex high-density polyethylene, Marlex low-density polyethylene, linear low density polyethylene (for example REXELL®), polyester, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), poly paraphenylene terephthalamide (for example, KEVLAR®), polysulfone, nylon, nylon-12 (such as GRILAMID® available from EMS American Grilon), perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), polycarbonates, ionomers, biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like. In some embodiments sheath material can be blended with a liquid crystal polymer (LCP). For example, the mixture can contain up to about 6% LCP. This has been found to enhance torqueability. By employing selection of materials and processing techniques, thermoplastic, solvent soluble, and thermosetting variants of these and other materials can be employed to achieve the desired results. Some examples of suitable coating materials may include silicone and the like, hydrophilic polymers such as high-density polyethylene (HDPE), polytetrafluoroethylene (PTFE), polyarylene oxides, polyvinylpyrolidones, polyvinylalcohols, hydroxy alkyl cellulosics, algins, saccharides, caprolactones, and the like, and mixtures and combinations thereof. Some coating polymers may be blended among themselves or with formulated amounts of water insoluble compounds (including some polymers) to yield coatings with suitable lubricity, bonding, and solubility. Some other examples of such coatings and materials and methods used to create such coatings can be found in U.S. Pat. Nos. 6,139,510 and 5,772,609, which are incorporated herein by reference.
A coating and/or sheath may be formed, for example, by coating, extrusion, co-extrusion, interrupted layer co-extrusion (ILC), or fusing several segments end-to-end. The layer may have a uniform stiffness or a gradual reduction in stiffness from the proximal end to the distal end thereof. The gradual reduction in stiffness may be continuous as by ILC or may be stepped as by fusing together separate extruded tubular segments. The outer layer may be impregnated with a radiopaque filler material to facilitate radiographic visualization. Those skilled in the art will recognize that these materials can vary widely without deviating from the scope of the present invention.
The length of the guidewire 10 is typically dictated by the length and flexibility characteristics desired in the final medical device. For example, proximal section 12 may have a length in the range of about 20 to about 300 centimeters or more, the distal section 14 may have a length in the range of about 3 to about 50 centimeters or more, and the medical device 10 may have a total length in the range of about 25 to about 350 centimeters or more. It can be appreciated that alterations in the length of sections and/or of the guidewire 10 as a whole can be made without departing from the spirit of the invention.
It should also be understood that a broad variety of other structures and/or components may be used in the guidewire construction. Some examples of other structures that may be used in the guidewire 10 include one or more coil members, braids, shaping or safety structures, such as a shaping ribbon or wire, marker members, such as marker bands or coils, centering structures for centering the core wire within the tubular member, such as a centering ring, an extension system, for example, to effectively lengthen the guidewire for aiding in exchanging other devices, or the like, or other structures. Those of skill in the art and others will recognize that the materials, structure, and dimensions of the guidewire may be dictated primary by the desired characteristics and function of the final guidewire, and that any of a broad range of materials, structures, and dimensions can be used.
Refer now to
Refer now to
Refer now to
Refer now to
The present invention should not be considered limited to the particular examples described above, but rather should be understood to cover all aspects of the invention as fairly set out in the attached claims. Various modifications, equivalent processes, as well as numerous structures to which the present invention may be applicable will be readily apparent to those of skill in the art to which the present invention is directed upon review of the instant specification. It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. For example, although set forth with specific reference to guidewires in some of the example embodiments shown in the Figures and discussed above, the invention may relate to virtually any medical device including an elongate tubular member having a distal section including a plurality of angled slots defined therein that form a generally spiral shaped pattern about the longitudinal axis. Such structure may aid a user of the device in crossing an occlusion in a blood. For example, the invention may be applied to medical devices such as a balloon catheter, an atherectomy catheter, a drug delivery catheter, a stent delivery catheter, an endoscope, a fluid delivery device, other infusion or aspiration devices, delivery (i.e. implantation) devices, and the like. Thus, while the Figures and descriptions above are directed toward a guidewire, in other applications, sizes in terms of diameter, width, and length may vary widely, depending upon the desired properties of a particular device. The scope of the invention is, of course, defined in the language in which the appended claims are expressed.
Number | Name | Date | Kind |
---|---|---|---|
1553227 | Feyk et al. | Sep 1925 | A |
1866888 | Hawley | Jul 1932 | A |
2275827 | Plensler | Mar 1942 | A |
2413805 | Vickers | Jan 1947 | A |
2441166 | Raspert | May 1948 | A |
2561890 | Stoddard | Jul 1951 | A |
2722614 | Fryklund | Nov 1955 | A |
2857536 | Light | Oct 1958 | A |
2864017 | Waltscheff | Dec 1958 | A |
2871793 | Michie et al. | Feb 1959 | A |
3249776 | Anderson et al. | May 1966 | A |
3322984 | Anderson | May 1967 | A |
3334253 | Hill | Aug 1967 | A |
3363470 | Yavne | Jan 1968 | A |
3452227 | Welch | Jun 1969 | A |
3452742 | Muller | Jul 1969 | A |
3463953 | Maxwell | Aug 1969 | A |
3512019 | Durand | May 1970 | A |
3544868 | Bates | Dec 1970 | A |
3625200 | Muller | Dec 1971 | A |
3686990 | Margolien | Aug 1972 | A |
3841308 | Tate | Oct 1974 | A |
3890977 | Wilson | Jun 1975 | A |
3906938 | Fleischhacker | Sep 1975 | A |
4000672 | Sitterer et al. | Jan 1977 | A |
4003369 | Heilman et al. | Jan 1977 | A |
4020829 | Willson et al. | May 1977 | A |
4030503 | Clark, III | Jun 1977 | A |
4142119 | Madey | Feb 1979 | A |
4215703 | Wilson | Aug 1980 | A |
4330725 | Hintz | May 1982 | A |
4425919 | Alston, Jr. et al. | Jan 1984 | A |
4476754 | Ducret | Oct 1984 | A |
4482828 | Vergues et al. | Nov 1984 | A |
4545390 | Leary | Oct 1985 | A |
4551292 | Fletcher et al. | Nov 1985 | A |
4563181 | Wijayarathna et al. | Jan 1986 | A |
4574670 | Johnson | Mar 1986 | A |
4580551 | Siegmund et al. | Apr 1986 | A |
4583404 | Bernard et al. | Apr 1986 | A |
4635270 | Gürs | Jan 1987 | A |
4665906 | Jervis | May 1987 | A |
4706671 | Weinrib | Nov 1987 | A |
4721117 | Mar et al. | Jan 1988 | A |
4737153 | Shimamura et al. | Apr 1988 | A |
4762130 | Fogarty et al. | Aug 1988 | A |
4763647 | Gambale | Aug 1988 | A |
4774949 | Fogarty | Oct 1988 | A |
4781092 | Gaiser | Nov 1988 | A |
4781186 | Simpson et al. | Nov 1988 | A |
4786220 | Fildes et al. | Nov 1988 | A |
4790331 | Okada et al. | Dec 1988 | A |
4800890 | Cramer | Jan 1989 | A |
4811743 | Stevens | Mar 1989 | A |
4817613 | Jaraczewski et al. | Apr 1989 | A |
4827941 | Taylor et al. | May 1989 | A |
4831858 | Yoshizawa | May 1989 | A |
4832047 | Sepetka et al. | May 1989 | A |
4846186 | Box et al. | Jul 1989 | A |
4846193 | Tremulis et al. | Jul 1989 | A |
4863442 | DeMello et al. | Sep 1989 | A |
4867173 | Leoni | Sep 1989 | A |
4875489 | Messner et al. | Oct 1989 | A |
4884579 | Engelson | Dec 1989 | A |
4911148 | Sosnowski et al. | Mar 1990 | A |
4917102 | Miller et al. | Apr 1990 | A |
4922164 | Jacobsen et al. | May 1990 | A |
4922777 | Kawabata | May 1990 | A |
4932959 | Horzewski et al. | Jun 1990 | A |
4934380 | Toledo | Jun 1990 | A |
4953553 | Tremulis | Sep 1990 | A |
4954022 | Underwood et al. | Sep 1990 | A |
4955384 | Taylor et al. | Sep 1990 | A |
4955862 | Sepetka | Sep 1990 | A |
4960410 | Pinchuk | Oct 1990 | A |
4964409 | Tremulis | Oct 1990 | A |
4966163 | Kraus et al. | Oct 1990 | A |
4968306 | Huss et al. | Nov 1990 | A |
4979951 | Simpson | Dec 1990 | A |
4985022 | Fearnot et al. | Jan 1991 | A |
4989608 | Ratner | Feb 1991 | A |
4990143 | Sheridan | Feb 1991 | A |
4994069 | Ritchart et al. | Feb 1991 | A |
4998923 | Samson et al. | Mar 1991 | A |
5007434 | Doyle et al. | Apr 1991 | A |
5009137 | Dannatt | Apr 1991 | A |
5040543 | Badera et al. | Aug 1991 | A |
5050606 | Tremulis | Sep 1991 | A |
5052404 | Hodgson | Oct 1991 | A |
5059177 | Alcebo et al. | Oct 1991 | A |
5063935 | Gamble | Nov 1991 | A |
5095915 | Engelson | Mar 1992 | A |
5106455 | Jacobsen et al. | Apr 1992 | A |
5109830 | Cho | May 1992 | A |
5125395 | Adair | Jun 1992 | A |
5135531 | Shiber | Aug 1992 | A |
5144959 | Gambale et al. | Sep 1992 | A |
5147317 | Shank et al. | Sep 1992 | A |
5181668 | Tsuji et al. | Jan 1993 | A |
5205830 | Dassa et al. | Apr 1993 | A |
5211183 | Wilson | May 1993 | A |
5238004 | Sahatjian et al. | Aug 1993 | A |
5242759 | Hall | Sep 1993 | A |
5243996 | Hall | Sep 1993 | A |
5250069 | Nobuyoshi et al. | Oct 1993 | A |
5254106 | Feaster | Oct 1993 | A |
5254107 | Soltesz | Oct 1993 | A |
5256144 | Kraus et al. | Oct 1993 | A |
5257974 | Cox | Nov 1993 | A |
5259393 | Corso, Jr. et al. | Nov 1993 | A |
5267979 | Appling et al. | Dec 1993 | A |
5267982 | Sylvanowicz | Dec 1993 | A |
5279562 | Sirhan et al. | Jan 1994 | A |
5282484 | Reger | Feb 1994 | A |
5284128 | Hart | Feb 1994 | A |
5300032 | Hibbs et al. | Apr 1994 | A |
5304131 | Paskar | Apr 1994 | A |
5306252 | Yutori et al. | Apr 1994 | A |
5308354 | Zacca et al. | May 1994 | A |
5308435 | Ruggles et al. | May 1994 | A |
5315906 | Ferenczi et al. | May 1994 | A |
5333620 | Moutafis et al. | Aug 1994 | A |
5334145 | Lundquist et al. | Aug 1994 | A |
5336205 | Zenzen et al. | Aug 1994 | A |
5341818 | Abrams et al. | Aug 1994 | A |
5345937 | Middleman et al. | Sep 1994 | A |
5345945 | Hodgson et al. | Sep 1994 | A |
5358493 | Schweich et al. | Oct 1994 | A |
5365942 | Shank | Nov 1994 | A |
5365943 | Jansen | Nov 1994 | A |
5366464 | Belknap | Nov 1994 | A |
5368564 | Savage | Nov 1994 | A |
5376084 | Bacich et al. | Dec 1994 | A |
5381782 | DeLaRama et al. | Jan 1995 | A |
5406960 | Corso, Jr. | Apr 1995 | A |
5411476 | Abrams | May 1995 | A |
5423799 | Shiu | Jun 1995 | A |
5437288 | Schwartz et al. | Aug 1995 | A |
5438993 | Lynch et al. | Aug 1995 | A |
5439000 | Gunderson et al. | Aug 1995 | A |
5441483 | Avitall | Aug 1995 | A |
5441489 | Utsumi et al. | Aug 1995 | A |
5447812 | Fukuda et al. | Sep 1995 | A |
5460187 | Daigle et al. | Oct 1995 | A |
5470330 | Goldenberg et al. | Nov 1995 | A |
5477856 | Lundquist | Dec 1995 | A |
5496294 | Hergenrother et al. | Mar 1996 | A |
5497785 | Viera | Mar 1996 | A |
5507301 | Wasicek et al. | Apr 1996 | A |
5507729 | Lindenberg et al. | Apr 1996 | A |
5507751 | Goode et al. | Apr 1996 | A |
5507766 | Kugo et al. | Apr 1996 | A |
5514128 | Hillsman et al. | May 1996 | A |
5520194 | Miyata et al. | May 1996 | A |
5520645 | Imran et al. | May 1996 | A |
5531719 | Takahashi | Jul 1996 | A |
5533985 | Wang | Jul 1996 | A |
5546958 | Thorud et al. | Aug 1996 | A |
5551444 | Finlayson | Sep 1996 | A |
5554139 | Okajima | Sep 1996 | A |
5562619 | Mirarchi et al. | Oct 1996 | A |
5569197 | Helmus et al. | Oct 1996 | A |
5569200 | Umeno et al. | Oct 1996 | A |
5569218 | Berg | Oct 1996 | A |
5571073 | Castillo | Nov 1996 | A |
5573520 | Schwartz et al. | Nov 1996 | A |
5584821 | Hobbs et al. | Dec 1996 | A |
5584843 | Wulfman et al. | Dec 1996 | A |
5599326 | Carter | Feb 1997 | A |
5599492 | Engelson | Feb 1997 | A |
5601539 | Corso, Jr. | Feb 1997 | A |
5605162 | Mirzaee et al. | Feb 1997 | A |
5622184 | Ashby et al. | Apr 1997 | A |
5630806 | Inagaki et al. | May 1997 | A |
5637089 | Abrams et al. | Jun 1997 | A |
5656011 | Uihlein et al. | Aug 1997 | A |
5658264 | Samson et al. | Aug 1997 | A |
5666968 | Imran et al. | Sep 1997 | A |
5666969 | Urick et al. | Sep 1997 | A |
5669926 | Aust et al. | Sep 1997 | A |
5676659 | McGurk | Oct 1997 | A |
5676697 | McDonald | Oct 1997 | A |
5682894 | Orr et al. | Nov 1997 | A |
5690120 | Jacobsen et al. | Nov 1997 | A |
5695506 | Pike et al. | Dec 1997 | A |
5707350 | Krause et al. | Jan 1998 | A |
5720300 | Fagan et al. | Feb 1998 | A |
5720749 | Rupp | Feb 1998 | A |
5722609 | Murakami | Mar 1998 | A |
5728063 | Preissman et al. | Mar 1998 | A |
5738742 | Stevens | Apr 1998 | A |
5746701 | Noone | May 1998 | A |
5769830 | Parker | Jun 1998 | A |
5772609 | Nguyen et al. | Jun 1998 | A |
5779721 | Nash | Jul 1998 | A |
5782809 | Umeno et al. | Jul 1998 | A |
5788653 | Lorenzo | Aug 1998 | A |
5788654 | Schwager | Aug 1998 | A |
5788707 | Del Toro et al. | Aug 1998 | A |
5792124 | Horrigan et al. | Aug 1998 | A |
5797856 | Frisbie et al. | Aug 1998 | A |
5800454 | Jacobsen et al. | Sep 1998 | A |
5807075 | Jacobsen et al. | Sep 1998 | A |
5807249 | Qin et al. | Sep 1998 | A |
5810885 | Zinger | Sep 1998 | A |
5813996 | St. Germain et al. | Sep 1998 | A |
5820612 | Berg | Oct 1998 | A |
5827225 | Ma Schwab | Oct 1998 | A |
5827242 | Follmer et al. | Oct 1998 | A |
5833632 | Jacobsen et al. | Nov 1998 | A |
5836926 | Peterson et al. | Nov 1998 | A |
5843050 | Jones et al. | Dec 1998 | A |
5843244 | Pelton et al. | Dec 1998 | A |
5851203 | van Muiden | Dec 1998 | A |
5895378 | Nita | Apr 1999 | A |
5897537 | Berg et al. | Apr 1999 | A |
5902254 | Magram | May 1999 | A |
5902290 | Peacock, III et al. | May 1999 | A |
5904657 | Unsworth et al. | May 1999 | A |
5906618 | Larson, III | May 1999 | A |
5911715 | Berg et al. | Jun 1999 | A |
5911717 | Jacobsen et al. | Jun 1999 | A |
5916177 | Schwager | Jun 1999 | A |
5916178 | Noone | Jun 1999 | A |
5916194 | Jacobsen et al. | Jun 1999 | A |
5931830 | Jacobsen et al. | Aug 1999 | A |
5935108 | Katoh et al. | Aug 1999 | A |
5947940 | Beisel | Sep 1999 | A |
5951539 | Nita et al. | Sep 1999 | A |
5954651 | Berg et al. | Sep 1999 | A |
5971975 | Mills et al. | Oct 1999 | A |
5972019 | Engelson et al. | Oct 1999 | A |
6001068 | Uchino et al. | Dec 1999 | A |
6004279 | Crowley et al. | Dec 1999 | A |
6014919 | Jacobsen et al. | Jan 2000 | A |
6017319 | Jacobsen et al. | Jan 2000 | A |
6019772 | Shefaram et al. | Feb 2000 | A |
6022343 | Johnson et al. | Feb 2000 | A |
6022369 | Jacobsen et al. | Feb 2000 | A |
6024730 | Pagan | Feb 2000 | A |
6027461 | Walker et al. | Feb 2000 | A |
6042553 | Solar et al. | Mar 2000 | A |
6045547 | Ren et al. | Apr 2000 | A |
6048339 | Zirps et al. | Apr 2000 | A |
6056702 | Lorenzo | May 2000 | A |
6063101 | Jacobsen et al. | May 2000 | A |
6063200 | Jacobsen et al. | May 2000 | A |
6066361 | Jacobsen et al. | May 2000 | A |
6106485 | McMahon | Aug 2000 | A |
6106488 | Fleming et al. | Aug 2000 | A |
6139510 | Palermo | Oct 2000 | A |
6165292 | Abrams et al. | Dec 2000 | A |
6171296 | Chow | Jan 2001 | B1 |
6183410 | Jacobsen et al. | Feb 2001 | B1 |
6193686 | Estrada et al. | Feb 2001 | B1 |
6197014 | Samson et al. | Mar 2001 | B1 |
6203485 | Urick | Mar 2001 | B1 |
6228073 | Noone et al. | May 2001 | B1 |
6235042 | Katzman | May 2001 | B1 |
6248082 | Jafari | Jun 2001 | B1 |
6251092 | Qin et al. | Jun 2001 | B1 |
6254549 | Ramzipoor | Jul 2001 | B1 |
6260458 | Jacobsen et al. | Jul 2001 | B1 |
6273404 | Holman et al. | Aug 2001 | B1 |
6290656 | Boyle et al. | Sep 2001 | B1 |
6296616 | McMahon | Oct 2001 | B1 |
6296631 | Chow | Oct 2001 | B2 |
6302870 | Jacobsen et al. | Oct 2001 | B1 |
6325790 | Trotta | Dec 2001 | B1 |
6338725 | Hermann et al. | Jan 2002 | B1 |
6346091 | Jacobsen et al. | Feb 2002 | B1 |
6352515 | Anderson et al. | Mar 2002 | B1 |
6355005 | Powell et al. | Mar 2002 | B1 |
6355027 | Le et al. | Mar 2002 | B1 |
6368315 | Gillis et al. | Apr 2002 | B1 |
6368316 | Jansen et al. | Apr 2002 | B1 |
6375628 | Zadno-Azizi et al. | Apr 2002 | B1 |
6375774 | Lunn et al. | Apr 2002 | B1 |
6379369 | Abrams et al. | Apr 2002 | B1 |
6390993 | Cornish et al. | May 2002 | B1 |
6398758 | Jacobsen et al. | Jun 2002 | B1 |
6428489 | Jacobsen et al. | Aug 2002 | B1 |
6428512 | Anderson et al. | Aug 2002 | B1 |
6431039 | Jacobsen et al. | Aug 2002 | B1 |
6440088 | Jacobsen | Aug 2002 | B1 |
6478778 | Jacobsen et al. | Nov 2002 | B1 |
6488637 | Eder et al. | Dec 2002 | B1 |
6491648 | Cornish et al. | Dec 2002 | B1 |
6491671 | Larson, III et al. | Dec 2002 | B1 |
6508803 | Horikawa et al. | Jan 2003 | B1 |
6524301 | Wilson et al. | Feb 2003 | B1 |
6530934 | Jacobsen et al. | Mar 2003 | B1 |
6547779 | Levine et al. | Apr 2003 | B2 |
6553880 | Jacobsen et al. | Apr 2003 | B2 |
6556873 | Smits | Apr 2003 | B1 |
6579246 | Jacobsen et al. | Jun 2003 | B2 |
6591472 | Noone et al. | Jul 2003 | B1 |
6602280 | Chobotov | Aug 2003 | B2 |
6610046 | Usami et al. | Aug 2003 | B1 |
6623448 | Slater | Sep 2003 | B2 |
6636758 | Sanchez et al. | Oct 2003 | B2 |
6638266 | Wilson et al. | Oct 2003 | B2 |
6652508 | Griffin et al. | Nov 2003 | B2 |
6682493 | Mirigian | Jan 2004 | B2 |
6684874 | Mizek et al. | Feb 2004 | B2 |
6712826 | Lui | Mar 2004 | B2 |
6730095 | Olson, Jr. et al. | May 2004 | B2 |
6749560 | Konstorum et al. | Jun 2004 | B1 |
6766720 | Jacobsen et al. | Jul 2004 | B1 |
6777644 | Peacock, III et al. | Aug 2004 | B2 |
6811544 | Schaer | Nov 2004 | B2 |
6837898 | Boyle et al. | Jan 2005 | B2 |
6866642 | Kellerman et al. | Mar 2005 | B2 |
6875949 | Hall | Apr 2005 | B2 |
6887235 | O'Connor et al. | May 2005 | B2 |
6918882 | Skujins et al. | Jul 2005 | B2 |
6997937 | Jacobsen et al. | Feb 2006 | B2 |
7001369 | Griffin et al. | Feb 2006 | B2 |
7074197 | Reynolds et al. | Jul 2006 | B2 |
20020019599 | Rooney et al. | Feb 2002 | A1 |
20030009208 | Snyder et al. | Jan 2003 | A1 |
20030060732 | Jacobsen et al. | Mar 2003 | A1 |
20030069522 | Jacobsen et al. | Apr 2003 | A1 |
20030139763 | Duerig et al. | Jul 2003 | A1 |
20040010194 | Kamiyama | Jan 2004 | A1 |
20040111044 | Davis et al. | Jun 2004 | A1 |
20040153110 | Kurz et al. | Aug 2004 | A1 |
20040167437 | Sharrow et al. | Aug 2004 | A1 |
20040167441 | Reynolds et al. | Aug 2004 | A1 |
20040181174 | Davis et al. | Sep 2004 | A2 |
20040181176 | Jafari et al. | Sep 2004 | A1 |
20040210163 | Osawa et al. | Oct 2004 | A1 |
20050065456 | Eskuri | Mar 2005 | A1 |
20060100687 | Fahey et al. | May 2006 | A1 |
20060189896 | Davis et al. | Aug 2006 | A1 |
20060264904 | Kerby et al. | Nov 2006 | A1 |
20080021347 | Jacobsen et al. | Jan 2008 | A1 |
20080021348 | Jacobsen et al. | Jan 2008 | A1 |
20080021400 | Jacobsen et al. | Jan 2008 | A1 |
20080021401 | Jacobsen et al. | Jan 2008 | A1 |
20080021402 | Jacobsen et al. | Jan 2008 | A1 |
20080021403 | Jacobsen et al. | Jan 2008 | A1 |
20080021404 | Jacobsen et al. | Jan 2008 | A1 |
20080021405 | Jacobsen et al. | Jan 2008 | A1 |
20080021406 | Jacobsen et al. | Jan 2008 | A1 |
20080021407 | Jacobsen et al. | Jan 2008 | A1 |
20080021408 | Jacobsen et al. | Jan 2008 | A1 |
20080077119 | Snyder et al. | Mar 2008 | A1 |
Number | Date | Country |
---|---|---|
723040 | Dec 1997 | AU |
733966 | Apr 1998 | AU |
PI 9712829 | Sep 1997 | BR |
2266685 | May 2006 | CA |
1230914 | Oct 1999 | CN |
2539191 | Mar 1976 | DE |
0 045 931 | Feb 1982 | EP |
0 069 522 | Jan 1983 | EP |
0 087 933 | Sep 1983 | EP |
0 111 044 | Jun 1984 | EP |
0 181 174 | May 1986 | EP |
0377453 | Jul 1990 | EP |
0 565 065 | Jun 1996 | EP |
0 778 038 | Jun 1997 | EP |
0 778 039 | Jun 1997 | EP |
0 778 040 | Jun 1997 | EP |
0 812 599 | Dec 1997 | EP |
0 865 772 | Sep 1998 | EP |
0 865 773 | Sep 1998 | EP |
0 521 595 | May 1999 | EP |
0 917 885 | May 1999 | EP |
0 937 481 | Aug 1999 | EP |
0 790 066 | Apr 2000 | EP |
0 608 853 | Apr 2003 | EP |
0 935 947 | Dec 2004 | EP |
0 934 141 | Nov 2005 | EP |
2214354 | Aug 1989 | GB |
2257269 | Jan 1993 | GB |
5-8522 | Jan 1983 | JP |
60091858 | May 1985 | JP |
61022752 | Jan 1986 | JP |
62023361 | Jan 1987 | JP |
62089470 | Apr 1987 | JP |
62299277 | Dec 1987 | JP |
6393516 | Apr 1988 | JP |
63-181774 | Jul 1988 | JP |
63217966 | Sep 1988 | JP |
1089956 | Apr 1989 | JP |
1135363 | May 1989 | JP |
1158936 | Jun 1989 | JP |
2107268 | Apr 1990 | JP |
03-122850 | Dec 1991 | JP |
4061840 | Feb 1992 | JP |
4099963 | Mar 1992 | JP |
4213069 | Aug 1992 | JP |
4213070 | Aug 1992 | JP |
4236965 | Aug 1992 | JP |
5149969 | Jun 1993 | JP |
5-506806 | Oct 1993 | JP |
5-309159 | Nov 1993 | JP |
5-507857 | Nov 1993 | JP |
6-501179 | Feb 1994 | JP |
631749 | Apr 1994 | JP |
6169996 | Jun 1994 | JP |
6-63224 | Sep 1994 | JP |
6312313 | Nov 1994 | JP |
728562 | May 1995 | JP |
7124164 | May 1995 | JP |
7124263 | May 1995 | JP |
7136280 | May 1995 | JP |
7148264 | Jun 1995 | JP |
7505561 | Jun 1995 | JP |
7037199 | Jul 1995 | JP |
7185009 | Jul 1995 | JP |
7255855 | Oct 1995 | JP |
7275366 | Oct 1995 | JP |
751067 | Nov 1995 | JP |
8-229888 | Sep 1996 | JP |
8509141 | Oct 1996 | JP |
8317988 | Dec 1996 | JP |
9000164 | Apr 1997 | JP |
9-276413 | Oct 1997 | JP |
9276413 | Oct 1997 | JP |
9-294813 | Nov 1997 | JP |
9294813 | Nov 1997 | JP |
10-118193 | May 1998 | JP |
10-305039 | Nov 1998 | JP |
10328191 | Dec 1998 | JP |
11-226131 | Aug 1999 | JP |
11-267224 | Oct 1999 | JP |
3081831 | Jun 2000 | JP |
2000197704 | Jul 2000 | JP |
2000-510722 | Aug 2000 | JP |
2000-511083 | Aug 2000 | JP |
2001-500808 | Jan 2001 | JP |
2002-529137 | Sep 2002 | JP |
2002-542901 | Dec 2002 | JP |
2002-543896 | Dec 2002 | JP |
2003-517893 | Jun 2003 | JP |
2005-534407 | Nov 2005 | JP |
712908 | Jan 1980 | SU |
758421 | Aug 1980 | SU |
1529365 | Dec 1989 | SU |
WO 9002520 | Mar 1990 | WO |
WO 9113364 | Sep 1991 | WO |
WO 9204072 | Mar 1992 | WO |
WO 9207619 | May 1992 | WO |
WO 9304722 | Mar 1993 | WO |
WO 9311313 | Jun 1993 | WO |
WO 9524236 | Sep 1995 | WO |
WO 9619255 | Jun 1996 | WO |
WO 9710022 | Mar 1997 | WO |
WO 9725914 | Jul 1997 | WO |
WO 9743949 | Nov 1997 | WO |
WO 9744083 | Nov 1997 | WO |
WO 9744086 | Nov 1997 | WO |
WO 9810694 | Mar 1998 | WO |
9904847 | Feb 1999 | WO |
WO 9911313 | Mar 1999 | WO |
WO 0027303 | May 2000 | WO |
WO 0030710 | Jun 2000 | WO |
WO 0048645 | Aug 2000 | WO |
WO 0057943 | Oct 2000 | WO |
WO 0066199 | Nov 2000 | WO |
WO 0067845 | Nov 2000 | WO |
WO 0072907 | Dec 2000 | WO |
WO 0128620 | Apr 2001 | WO |
0136034 | May 2001 | WO |
0145912 | Jun 2001 | WO |
WO 0145773 | Jun 2001 | WO |
WO 0193920 | Dec 2001 | WO |
WO 0213682 | Feb 2002 | WO |
WO 02062540 | Aug 2002 | WO |
WO 03004086 | Jan 2003 | WO |
WO 03008148 | Jan 2003 | WO |
WO 2004012804 | Feb 2004 | WO |
2004047899 | Jun 2004 | WO |
Entry |
---|
“Mechanical Design and Systems Handbook”, H.A. Rothbart, 1964, p. 33-13 (one sheet). |
Number | Date | Country | |
---|---|---|---|
20080147170 A1 | Jun 2008 | US |